Richard Solomon1, Paul Gordon2, Steven V Manoukian3, J Dawn Abbott4, Dean J Kereiakes5, Allen Jeremias6, Michael Kim7, Harold L Dauerman8. 1. Department of Medicine, University of Vermont Medical Center, Burlington, Vermont; Richard.solomon@vtmednet.org. 2. Division of Cardiology, Miriam Hospital, Providence, Rhode Island; 3. Sarah Connon Research Institute, Hospital Corporation of America, Nashville, Tennessee; 4. Division of Cardiology, Rhode Island Hospital, Providence, Rhode Island; 5. Christ Hospital Heart and Vascular Center, Lindner Research Center, Cincinnati, Ohio; 6. Division of Cardiology, Stony Brook University Hospital, Stony Brook, New York; and. 7. Mount Sinai Hospital, New York City, New York. 8. Department of Medicine, University of Vermont Medical Center, Burlington, Vermont;
Abstract
BACKGROUND AND OBJECTIVES:Sodium bicarbonate has been proposed for protection of the kidney from contrast-induced AKI (CIAKI). However, the effects of bicarbonate on long-term important clinical outcomes are uncertain. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In a prospective, double-blind, multicenter randomized clinical trial, 391 patients with an eGFR<45 ml/min per 1.73 m(2) undergoing elective coronary or peripheral angiography were randomized to an infusion with a high dose of isotonic sodium bicarbonate (target 2.0 mEq/kg) or a similar molar amount of isotonic sodium chloride. The primary outcome was a composite of mortality, dialysis, or a sustained 20% reduction in eGFR at 6 months. RESULTS: There were 391 patients enrolled between March 2010 and May 2012. The incidence of the primary outcome was 14.9% in the bicarbonate group and 16.3% in the control group in the intention-to-treat population (P=0.78). There was also no difference in the incidence of CIAKI between the treatment groups (14.5% versus 12.1%, respectively; P=0.20). CIAKI was associated with a higher incidence of sustained loss of kidney function at 6 months compared with those without CIAKI (21.2% versus 7.7%, respectively; P=0.06). CONCLUSIONS: High-dose sodium bicarbonate infusion in patients with eGFR<45 ml/min per 1.73 m(2) undergoing angiography did not demonstrate a difference in incidence of the composite of death, dialysis, or sustained 6-month reduction in eGFR or CIAKI compared with sodium chloride.
RCT Entities:
BACKGROUND AND OBJECTIVES:Sodium bicarbonate has been proposed for protection of the kidney from contrast-induced AKI (CIAKI). However, the effects of bicarbonate on long-term important clinical outcomes are uncertain. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In a prospective, double-blind, multicenter randomized clinical trial, 391 patients with an eGFR<45 ml/min per 1.73 m(2) undergoing elective coronary or peripheral angiography were randomized to an infusion with a high dose of isotonic sodium bicarbonate (target 2.0 mEq/kg) or a similar molar amount of isotonic sodium chloride. The primary outcome was a composite of mortality, dialysis, or a sustained 20% reduction in eGFR at 6 months. RESULTS: There were 391 patients enrolled between March 2010 and May 2012. The incidence of the primary outcome was 14.9% in the bicarbonate group and 16.3% in the control group in the intention-to-treat population (P=0.78). There was also no difference in the incidence of CIAKI between the treatment groups (14.5% versus 12.1%, respectively; P=0.20). CIAKI was associated with a higher incidence of sustained loss of kidney function at 6 months compared with those without CIAKI (21.2% versus 7.7%, respectively; P=0.06). CONCLUSIONS: High-dose sodium bicarbonate infusion in patients with eGFR<45 ml/min per 1.73 m(2) undergoing angiography did not demonstrate a difference in incidence of the composite of death, dialysis, or sustained 6-month reduction in eGFR or CIAKI compared with sodium chloride.
Authors: L Gruberg; G S Mintz; R Mehran; G Gangas; A J Lansky; K M Kent; A D Pichard; L F Satler; M B Leon Journal: J Am Coll Cardiol Date: 2000-11-01 Impact factor: 24.094
Authors: Somjot S Brar; Swapnil Hiremath; George Dangas; Roxana Mehran; Simerjeet K Brar; Martin B Leon Journal: Clin J Am Soc Nephrol Date: 2009-08-27 Impact factor: 8.237
Authors: Eric A J Hoste; Jan J De Waele; Sofie A Gevaert; Shigehiko Uchino; John A Kellum Journal: Nephrol Dial Transplant Date: 2009-08-23 Impact factor: 5.992
Authors: Roxana Mehran; Eve D Aymong; Eugenia Nikolsky; Zoran Lasic; Ioannis Iakovou; Martin Fahy; Gary S Mintz; Alexandra J Lansky; Jeffrey W Moses; Gregg W Stone; Martin B Leon; George Dangas Journal: J Am Coll Cardiol Date: 2004-10-06 Impact factor: 24.094
Authors: Gregory J Merten; W Patrick Burgess; Lee V Gray; Jeremiah H Holleman; Timothy S Roush; Glen J Kowalchuk; Robert M Bersin; Arl Van Moore; Charles A Simonton; Robert A Rittase; H James Norton; Thomas P Kennedy Journal: JAMA Date: 2004-05-19 Impact factor: 56.272
Authors: Devin S Zarkowsky; Caitlin W Hicks; Ian C Bostock; David H Stone; Mohammad Eslami; Philip P Goodney Journal: J Vasc Surg Date: 2016-07-29 Impact factor: 4.268